Abstract
Gastrointestinal stromal tumors (GISTs) are highly responsive to inhibitors of the KIT proto-oncogene receptor tyrosine kinase and platelet-derived
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have